I don't think they have the revenue to afford to borrow more. Who is going to buy their junk insurance trail commissions - which have remediation costs and growing cancellations?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025